Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_assertion type Assertion NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_head.
- NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_assertion description "[Using a modified quantitative reverse transcriptase (RT) PCR assay in 57 patients with acute myeloid leukaemia (AML) from a Swiss Phase III multicentre study (SAKK 30/85), we measured the m-RNA expression of the genes from the multidrug resistance gene 1 (MDR1), the multidrug resistance associated protein (MRP), glutathione-S-transferase (GST) pi, bcl-2 and topoisomerase (topo) IIalpha.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_provenance.
- NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_assertion evidence source_evidence_literature NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_provenance.
- NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_assertion SIO_000772 9338618 NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_provenance.
- NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_assertion wasDerivedFrom befree-20150227 NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_provenance.
- NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_assertion wasGeneratedBy ECO_0000203 NP802362.RAVUYVzLHiBf4jz1G4ViwBFxVTdAW3_vjkN_EcLcdkJbE130_provenance.